Arvinas, Inc. (ARVN) vs YD Bio Limited (YDES)

Arvinas, Inc. ARVN 6.97 −2.65%
YD Bio Limited YDES 5.92 −12.17%

Arvinas, Inc. and YD Bio Limited are both Biotechnology companies. Arvinas, Inc. and YD Bio Limited are of similar size ($477.5M and $468.2M).

Metric	ARVN	YDES	Biotechnology median
P/E	53.62	—	8.50
P/S	1.43	—	9.71
P/B	0.80	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	6.41	—	0.64
EV/Sales	(0.36)	—	9.21
Earnings yield	1.87%	—	(33.15%)
Free cash flow yield	(46.23%)	—	(25.50%)

Metric	ARVN	YDES	Biotechnology median
Gross margin	97.16%	—	65.16%
Operating margin	(5.72%)	—	0.00%
Net margin	2.94%	—	0.00%
Free cash flow margin	(65.93%)	—	0.00%
Return on equity	1.59%	—	(56.36%)
Return on assets	1.17%	—	(48.04%)
Return on invested capital	0.00%	—	0.00%

Metric	ARVN	YDES	Biotechnology median
Revenue growth (TTM)	(15.05%)	—	6.02%
EPS growth (last fiscal year)	58.84%	—	30.26%
Revenue growth, 5-year CAGR	58.93%	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ARVN	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	7.91	—	4.72
Net debt to EBITDA	5.62	—	0.96

Metric	ARVN	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	ARVN	YDES	Biotechnology median
Market cap	468.16m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack